✦ LIBER ✦

Effect and prognostic analysis of treatment for acute myeloid leukemia using Chinese drugs combined with chemotherapy

✍ Scribed by Xiao-mei Hu; Feng Liu; Chun-mei Zheng; Liu Li; Chi Liu; Shan-shan Zhang; Hai-yan Xiao; Xiao-hong Yang; Hong-zhi Wang; Yong-gang Xu; Nai-ping Hu; Rou Ma

Book ID: 107437368
Publisher: Chinese Association of Traditional and Western Medicine
Year: 2009
Tongue: English
Weight: 201 KB
Volume: 15
Category: Article
ISSN: 1672-0415
DOI: 10.1007/s11655-009-0193-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of acute myeloid leukemia with

Treatment of acute myeloid leukemia with a combination of intensive induction chemotherapy, early consolidation, splenectomy and long-term maintenance chemotherapy

✍ Dr. David Machover; Henry Rappaport; Léon Schwarzenberg; Jean-Louis Misset; Emma 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 660 KB

The authors developed a therapeutic regimen in which 33 patients aged I I to 61 years (mean 2 SE, 35.9 t 2.3 years) with acute myeloid leukemia (AML) were given intensive induction chemotherapy with Adriamycin (doxorubicin) (ADM), vincristine (VCR) and cytosine arabinoside (ARA-C). Twenty-nine of th

Results of intensive chemotherapy in 998

Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: : Predictive prognostic models for outcome

✍ Hagop Kantarjian; Susan O'Brien; Jorge Cortes; Francis Giles; Stefan Faderl; Eli 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

## Abstract ## BACKGROUND Elderly patients (age ≥ 65 years) with acute myeloid leukemia (AML) generally have a poor prognosis. AML‐type therapy results are often derived from studies in younger patients and may not apply to elderly AML. Many investigators and oncologists advocate, at times, only s

Analysis of efficacy and cost-effectiven

Analysis of efficacy and cost-effectiveness of high-dose arabinoside versus daunorubicin chemotherapy in older adult patients with acute myeloid leukemia by cytogenetic risk profile: retrospective review from China

✍ Bin-Tao Huang; Yu Wang; Qing-Feng Du; Jun Yang; Jessica Yu; Qing-Chun Zeng; Na X 📂 Article 📅 2011 🏛 Carden Jennings Publishing 🌐 English ⚖ 218 KB

The use of receiver operating characteri

The use of receiver operating characteristic analysis for detection of minimal residual disease using five-color multiparameter flow cytometry in acute myeloid leukemia identifies patients with high risk of relapse

✍ Adhra Al-Mawali; David Gillis; Ian Lewis 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 461 KB 👁 2 views

## Abstract ## Background: Multiparameter flow cytometry (MFC) has been shown to be a useful approach for detection of minimal residual disease (MRD). The aim of the study was to determine the optimal threshold that can separate patients into two groups in terms of leukemic residual cells and rela